Background There are no recognized pharmacological treatments for abdominal aortic
aneurysms (AAA), although statins are suggested to be beneficial. We sought to summarize …

The pathogenesis of the abdominal aortic aneurysm (AAA) shows several hallmarks of
atherosclerotic and atherothrombotic disease, but comprises an additional, predominant …

Purpose Abdominal aortic aneurysm is a common degenerative vascular disorder
associated with sudden death due to aortic rupture. This review describes epidemiology …

Background Studies have investigated the effects of gender on vascular surgery care.
However, to the best of our knowledge, no comprehensive synthesis of the literature has …

Objective—Abdominal aortic aneurysm (AAA) is an increasingly prevalent and ultimately
fatal disease with no effective pharmacological treatment. Because matrix degradation …

Abdominal aortic aneurysm is a vascular disease which, despite the fact that it shares
common risk factors with atherosclerosis, develops in parallel but as a partly independent …

Abdominal aortic aneurysm (AAA) disease, the local enlargement of the infrarenal aorta, is a
serious condition that causes many deaths, especially in men exceeding 65 years of age …

Objective There is no medical treatment proven to limit abdominal aortic aneurysm (AAA)
progression. This systematic review aimed to summarise available trial evidence on the …

Background Abdominal aortic aneurysm (AAA) is a potentially lethal disease with extremely
poor survival rates once the aneurysm ruptures. Statins may exert beneficial effects on the …

Objective The processes driving human abdominal aortic aneurysm (AAA) progression are
not fully understood. Although antiinflammatory and proteolytic strategies effectively quench …